These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 32234847)

  • 21. A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma.
    Weng J; Huang Z; Li Q; Huang Y; Chen S
    Int J Med Sci; 2023; 20(8):1046-1059. PubMed ID: 37484803
    [No Abstract]   [Full Text] [Related]  

  • 22. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker.
    Zhang D; Liang P; Xia B; Wu J; Hu X
    BMC Cancer; 2024 Aug; 24(1):987. PubMed ID: 39123194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma.
    Zhang Q; Hao L; Wang F; Yu Q; Wu S; Han C
    J Cell Mol Med; 2024 Jun; 28(11):e18410. PubMed ID: 38853457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
    Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
    Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
    Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
    BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between IL3 signaling pathway-related genes and immune checkpoint inhibitor efficacy in patients with renal cell carcinoma.
    Hou S; Gu T; Shi Y; Huang Y; Yao J; Luo P; Cao M; Zhang J; Lin A; Zhu W
    Cancer Biomark; 2023; 38(4):489-504. PubMed ID: 38043008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Chen C; Sheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211036233. PubMed ID: 34346239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune infiltration in renal cell carcinoma.
    Zhang S; Zhang E; Long J; Hu Z; Peng J; Liu L; Tang F; Li L; Ouyang Y; Zeng Z
    Cancer Sci; 2019 May; 110(5):1564-1572. PubMed ID: 30861269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between methylation of interferon regulatory factor 6 gene promoter in renal tissues and overall survival of patients with Kidney renal clear cell carcinoma].
    Zhang J; Chen C; Wei Y; Chen L; Shao P; Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Feb; 41(2):150-156. PubMed ID: 38311552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma.
    Zhou L; Zhou W; Li Y; Hua R
    Eur J Med Res; 2023 Sep; 28(1):321. PubMed ID: 37679761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.
    Fan X; Liu B; Wang Z; He D
    Aging (Albany NY); 2021 Mar; 13(6):8541-8562. PubMed ID: 33714201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.
    Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J
    Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-omics pan-cancer study of cuproptosis core gene
    Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
    Front Immunol; 2022; 13():981764. PubMed ID: 36605188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SLC11A1 promotes kidney renal clear cell carcinoma (KIRC) progression by remodeling the tumor microenvironment.
    Wu D; Zhou Y; Shi X; Yi X; Sheng Z; Fan L; Ge J; Cheng W; Zhou W; He H; Fu D
    Toxicol Appl Pharmacol; 2024 Jun; 487():116975. PubMed ID: 38762191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
    Xu L; He J; Cai Q; Li M; Pu X; Guo Y
    Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
    Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q
    BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.
    Liang F; Liang H; Li Z; Huang P
    Int Immunopharmacol; 2020 Sep; 86():106706. PubMed ID: 32570038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.